首页 > 最新文献

Journal of Obesity & Metabolic Syndrome最新文献

英文 中文
Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus. 分析 2 型糖尿病患者内脏脂肪组织生长分化因子-15 与 MicroRNA 的关系
IF 4.7 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-03-30 Epub Date: 2023-03-15 DOI: 10.7570/jomes22010
Dipayan Roy, Purvi Purohit, Manoj Khokhar, Anupama Modi, Ravindra Kumar Gayaprasad Shukla, Ramkaran Chaudhary, Shrimanjunath Sankanagoudar, Praveen Sharma

Background: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and peripheral blood mononuclear cells (PBMCs) in type 2 diabetes mellitus (T2DM) patients.

Methods: Sixty patients, equally divided into those with T2DM and non-diabetic controls, were recruited for gene expression analysis. Protein-protein interaction (STRING), target prediction (miRNet), and functional enrichment were conducted accordingly.

Results: Our study showed that VAT and PBMCs had similar expression profiles, where GDF-15 and miR-181b-5p were upregulated, whereas SMAD7 and miR-330-3p were downregulated. Serum GDF-15 could differentiate between T2DM and non-diabetic patients (P<0.001). Target prediction revealed a microRNA (miRNA)-messenger RNA regulatory network, transcription factors, and functional enrichment for the miRNA that suggested involvement in T2DM pathogenesis.

Conclusion: VAT GDF-15 is associated with insulin resistance and is possibly regulated by miR-181b-5p, miR-330-3p, and SMAD7 in T2DM.

背景:生长分化因子-15(GDF-15)与胰岛素抵抗和糖尿病有关。在这项研究中,我们确定了 GDF-15 与 miR-181b-5p、miR-330-3p、母亲抗截瘫同源物 7(SMAD7)以及 2 型糖尿病(T2DM)患者内脏脂肪组织(VAT)和外周血单核细胞(PBMCs)中胰岛素抵抗的关系:招募 60 名患者进行基因表达分析,这些患者平均分为 T2DM 患者和非糖尿病对照组。结果:我们的研究显示,VAT 和 PAT 的基因表达与 T2DM 患者的基因表达存在显著差异:结果:我们的研究表明,VAT 和 PBMCs 有相似的表达谱,其中 GDF-15 和 miR-181b-5p 上调,而 SMAD7 和 miR-330-3p 下调。血清 GDF-15 可以区分 T2DM 患者和非糖尿病患者(结论:VAT GDF-15 与降糖药物有关:VAT GDF-15 与 T2DM 患者的胰岛素抵抗有关,并可能受 miR-181b-5p、miR-330-3p 和 SMAD7 的调控。
{"title":"Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus.","authors":"Dipayan Roy, Purvi Purohit, Manoj Khokhar, Anupama Modi, Ravindra Kumar Gayaprasad Shukla, Ramkaran Chaudhary, Shrimanjunath Sankanagoudar, Praveen Sharma","doi":"10.7570/jomes22010","DOIUrl":"10.7570/jomes22010","url":null,"abstract":"<p><strong>Background: </strong>Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7), and insulin resistance in visceral adipose tissue (VAT) and peripheral blood mononuclear cells (PBMCs) in type 2 diabetes mellitus (T2DM) patients.</p><p><strong>Methods: </strong>Sixty patients, equally divided into those with T2DM and non-diabetic controls, were recruited for gene expression analysis. Protein-protein interaction (STRING), target prediction (miRNet), and functional enrichment were conducted accordingly.</p><p><strong>Results: </strong>Our study showed that VAT and PBMCs had similar expression profiles, where GDF-15 and miR-181b-5p were upregulated, whereas SMAD7 and miR-330-3p were downregulated. Serum GDF-15 could differentiate between T2DM and non-diabetic patients (<i>P</i><0.001). Target prediction revealed a microRNA (miRNA)-messenger RNA regulatory network, transcription factors, and functional enrichment for the miRNA that suggested involvement in T2DM pathogenesis.</p><p><strong>Conclusion: </strong>VAT GDF-15 is associated with insulin resistance and is possibly regulated by miR-181b-5p, miR-330-3p, and SMAD7 in T2DM.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"32 1","pages":"64-76"},"PeriodicalIF":4.7,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/75/jomes-32-1-64.PMC10088550.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9643116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bariatric Surgery in Kidney Transplant Candidates and Recipients: Experience at an Asian Center. 肾移植候选人和受者的减肥手术:在亚洲中心的经验。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes21090
Sarah Ying Tse Tan, Phong Ching Lee, Sonali Ganguly, Peng Chin Kek, Terence Kee, Quan Yao Ho, Sobhana Thangaraju

Background: Kidney transplant (KT) candidates and recipients with obesity experience more frequent complications such as infection, poorer allograft outcomes, diabetes, and mortality, limiting their eligibility for transplantation. Bariatric surgery (BS) is not commonly performed among KT patients given concerns about immunosuppression absorption, wound healing, infections, and graft outcomes. Its role has not been described before in an Asian KT patient setting.

Methods: A retrospective review of patients who underwent BS at the largest KT center in Singapore from 2008 to 2020 was conducted. Metabolic outcomes, immunosuppression doses, graft outcomes, and mortality were studied.

Results: Seven patients underwent BS and KT (4 underwent BS before KT, 3 underwent BS after KT; 4 underwent sleeve gastrectomy, 3 underwent gastric bypass). Mean total weight losses of 23.8% at 1 year and 18.6% at 5 years post-BS were achieved. Among the five patients with diabetes, glycemic control improved after BS. There were no deaths in the first 90 days or graft loss in the first year after KT and BS. Patients who underwent BS after KT had no significant changes in immunosuppression dose.

Conclusion: BS can be safely performed in KT recipients and candidates and results in sustainable weight losses and improvements in metabolic comorbidities. Although no major complications were observed in our study, close monitoring of this complex group of patients is imperative.

背景:肥胖的肾移植(KT)候选者和受体会经历更频繁的并发症,如感染、较差的同种异体移植结果、糖尿病和死亡率,限制了他们的移植资格。考虑到免疫抑制吸收、伤口愈合、感染和移植物结果,减肥手术(BS)不常用于KT患者。它的作用还没有描述在亚洲KT患者设置之前。方法:回顾性分析2008年至2020年在新加坡最大的KT中心接受BS治疗的患者。研究了代谢结果、免疫抑制剂量、移植物结果和死亡率。结果:7例患者合并BS和KT(4例在KT前发生BS, 3例在KT后发生BS;4例行袖式胃切除术,3例行胃旁路术。bs后1年平均总体重减轻23.8%,5年平均总体重减轻18.6%。5例糖尿病患者BS后血糖控制均有所改善。在KT和BS后的头90天内无死亡病例,一年内无移植物丢失。KT后BS患者免疫抑制剂量无明显变化。结论:BS可以安全地在KT受体和候选患者中进行,并导致持续的体重减轻和代谢合并症的改善。虽然在我们的研究中没有观察到主要的并发症,但密切监测这一复杂的患者群体是必要的。
{"title":"Bariatric Surgery in Kidney Transplant Candidates and Recipients: Experience at an Asian Center.","authors":"Sarah Ying Tse Tan,&nbsp;Phong Ching Lee,&nbsp;Sonali Ganguly,&nbsp;Peng Chin Kek,&nbsp;Terence Kee,&nbsp;Quan Yao Ho,&nbsp;Sobhana Thangaraju","doi":"10.7570/jomes21090","DOIUrl":"https://doi.org/10.7570/jomes21090","url":null,"abstract":"<p><strong>Background: </strong>Kidney transplant (KT) candidates and recipients with obesity experience more frequent complications such as infection, poorer allograft outcomes, diabetes, and mortality, limiting their eligibility for transplantation. Bariatric surgery (BS) is not commonly performed among KT patients given concerns about immunosuppression absorption, wound healing, infections, and graft outcomes. Its role has not been described before in an Asian KT patient setting.</p><p><strong>Methods: </strong>A retrospective review of patients who underwent BS at the largest KT center in Singapore from 2008 to 2020 was conducted. Metabolic outcomes, immunosuppression doses, graft outcomes, and mortality were studied.</p><p><strong>Results: </strong>Seven patients underwent BS and KT (4 underwent BS before KT, 3 underwent BS after KT; 4 underwent sleeve gastrectomy, 3 underwent gastric bypass). Mean total weight losses of 23.8% at 1 year and 18.6% at 5 years post-BS were achieved. Among the five patients with diabetes, glycemic control improved after BS. There were no deaths in the first 90 days or graft loss in the first year after KT and BS. Patients who underwent BS after KT had no significant changes in immunosuppression dose.</p><p><strong>Conclusion: </strong>BS can be safely performed in KT recipients and candidates and results in sustainable weight losses and improvements in metabolic comorbidities. Although no major complications were observed in our study, close monitoring of this complex group of patients is imperative.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"325-333"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/01/ab/jomes-31-4-325.PMC9828702.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9097786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recent Updates on Associations among Various Obesity Metrics and Cognitive Impairment: from Body Mass Index to Sarcopenic Obesity. 各种肥胖指标与认知障碍之间关系的最新进展:从体重指数到肌少性肥胖。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22058
Chan-Hee Jung, Ji-Oh Mok

Obesity and obesity-associated morbidity continues to be a major public health issue worldwide. Dementia is also a major health concern in aging societies and its prevalence has increased rapidly. Many epidemiologic studies have shown an association between obesity and cognitive impairment, but this relationship is not as well established as other comorbidities. Conflicting results related to the age and sex of participants, and the methodology used to define obesity and dementia may account for the uncertainty in whether obesity is a modifiable risk factor for dementia. More recently, sarcopenia and sarcopenic obesity have been reported to be associated with cognitive impairment. In addition, new mediators such as the muscle-myokine-brain axis and gut-microbiota-brain axis have been suggested and are attracting interest. In this review, we summarize recent evidence on the link between obesity and cognitive impairment, especially dementia. In particular, we focus on various metrics of obesity, from body mass index to sarcopenia and sarcopenic obesity.

肥胖和与肥胖相关的发病率仍然是世界范围内的一个主要公共卫生问题。痴呆症也是老龄化社会的一个主要健康问题,其患病率迅速上升。许多流行病学研究表明肥胖和认知障碍之间存在关联,但这种关系并不像其他合并症那样得到很好的证实。与参与者的年龄和性别有关的相互矛盾的结果,以及用于定义肥胖和痴呆的方法,可能解释了肥胖是否是痴呆的可改变风险因素的不确定性。最近,有报道称肌肉减少症和肌肉减少性肥胖与认知障碍有关。此外,新的介质如肌肉-肌因子-脑轴和肠道-微生物群-脑轴也被提出并引起了人们的兴趣。在这篇综述中,我们总结了最近关于肥胖和认知障碍,特别是痴呆之间联系的证据。我们特别关注肥胖的各种指标,从体重指数到肌肉减少症和肌肉减少性肥胖。
{"title":"Recent Updates on Associations among Various Obesity Metrics and Cognitive Impairment: from Body Mass Index to Sarcopenic Obesity.","authors":"Chan-Hee Jung,&nbsp;Ji-Oh Mok","doi":"10.7570/jomes22058","DOIUrl":"https://doi.org/10.7570/jomes22058","url":null,"abstract":"<p><p>Obesity and obesity-associated morbidity continues to be a major public health issue worldwide. Dementia is also a major health concern in aging societies and its prevalence has increased rapidly. Many epidemiologic studies have shown an association between obesity and cognitive impairment, but this relationship is not as well established as other comorbidities. Conflicting results related to the age and sex of participants, and the methodology used to define obesity and dementia may account for the uncertainty in whether obesity is a modifiable risk factor for dementia. More recently, sarcopenia and sarcopenic obesity have been reported to be associated with cognitive impairment. In addition, new mediators such as the muscle-myokine-brain axis and gut-microbiota-brain axis have been suggested and are attracting interest. In this review, we summarize recent evidence on the link between obesity and cognitive impairment, especially dementia. In particular, we focus on various metrics of obesity, from body mass index to sarcopenia and sarcopenic obesity.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"287-295"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/ab/jomes-31-4-287.PMC9828704.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10540319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Waist Circumference Measurement Site on Visceral Fat and Metabolic Risk in Youth. 腰围测量部位对青少年内脏脂肪及代谢风险的影响。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22046
SoJung Lee, Yejin Kim, Minsub Han

Although the rate of childhood obesity seems to have plateaued in recent years, the prevalence of obesity among children and adolescents remains high. Childhood obesity is a major public health concern as overweight and obese youth suffer from many co-morbid conditions once considered exclusive to adults. It is now well demonstrated that abdominal obesity as measured by waist circumference (WC) is an independent risk factor for cardiovascular disease and metabolic dysfunction in youth. Despite the strong associations between WC and cardiometabolic risk factors, there is no consensus regarding the optimal WC measurement sites to assess abdominal obesity and obesity-related health risk in children and adolescents. Currently, the WC measurement site that provides the best reflections of visceral fat and the best correlations with cardiometabolic risk factors is unclear. The purpose of this review is to explore whether WC measurement sites influence the relationships between WC, visceral fat, and cardiometabolic risk factors in children and adolescents.

虽然近年来儿童肥胖率似乎趋于稳定,但儿童和青少年的肥胖患病率仍然很高。儿童肥胖是一个主要的公共卫生问题,因为超重和肥胖的青少年患有许多曾经被认为是成年人独有的合并症。现在有充分的证据表明,以腰围(WC)衡量的腹部肥胖是青年心血管疾病和代谢功能障碍的独立危险因素。尽管腰围与心脏代谢危险因素之间存在很强的相关性,但对于评估儿童和青少年腹部肥胖和肥胖相关健康风险的最佳腰围测量点尚无共识。目前,最能反映内脏脂肪和与心脏代谢危险因素最佳相关性的WC测量位点尚不清楚。本综述的目的是探讨腰围测量地点是否影响儿童和青少年腰围、内脏脂肪和心脏代谢危险因素之间的关系。
{"title":"Influence of Waist Circumference Measurement Site on Visceral Fat and Metabolic Risk in Youth.","authors":"SoJung Lee,&nbsp;Yejin Kim,&nbsp;Minsub Han","doi":"10.7570/jomes22046","DOIUrl":"https://doi.org/10.7570/jomes22046","url":null,"abstract":"<p><p>Although the rate of childhood obesity seems to have plateaued in recent years, the prevalence of obesity among children and adolescents remains high. Childhood obesity is a major public health concern as overweight and obese youth suffer from many co-morbid conditions once considered exclusive to adults. It is now well demonstrated that abdominal obesity as measured by waist circumference (WC) is an independent risk factor for cardiovascular disease and metabolic dysfunction in youth. Despite the strong associations between WC and cardiometabolic risk factors, there is no consensus regarding the optimal WC measurement sites to assess abdominal obesity and obesity-related health risk in children and adolescents. Currently, the WC measurement site that provides the best reflections of visceral fat and the best correlations with cardiometabolic risk factors is unclear. The purpose of this review is to explore whether WC measurement sites influence the relationships between WC, visceral fat, and cardiometabolic risk factors in children and adolescents.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"296-302"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/f5/jomes-31-4-296.PMC9828705.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61-9). 肝纤维化和脂肪变性在代谢综合征(J Obes Metab Syndr 2022;31:61-9)。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22049
Young-Gyun Seo
J Obes Metab Syndr 2022;31:350-351 Nonalcoholic fatty liver disease has a worldwide prevalence of 25%, which includes diseases ranging from steatosis to steatohepatitis, and has a bidirectional association with metabolic syndrome (MetS).1 Although a few studies have investigated the association between liver fibrosis and MetS, their findings have been controversial. A recent cohort study of a large patient-centered medical home found that a heavy burden of MetS components was associated with high or indeterminate risk for advanced fibrosis when noninvasive indices were used.2 The results of studies evaluating fibrosis confirmed by liver biopsy were different. MetS was not significantly related to advanced liver fibrosis in biopsy-proven metabolic dysfunction-associated fatty liver disease patients3 and MetS was not associated with hepatic fibrosis among individuals with hereditary hemochromatosis.4 Gangireddy et al.5 reported useful findings in an article entitled “Hepatic fibrosis and steatosis in metabolic syndrome.” In analysis using National Health and Nutrition Examination Survey (NHANES) data, 26% of the participants had steatosis; 7.5% had fibrosis; and 3.3% had fibrosis without steatosis. The adjusted odds ratios were 4.12 for steatosis, 3.34 for fibrosis, and 2.67 for fibrosis without steatosis in participants with MetS compared to those without. The strength of Gangireddy et al.’s study5 is that it was population-scale study conducted in the United States. It also has some strengths in that hepatic fibrosis and steatosis were evaluated through liver ultrasound. However, as mentioned in the paper, the fact that hepatic fibrosis and steatosis were not evaluated by liver biopsy is one limitation, and it is necessary to consider a method to address this weakness. Another limitation is that noninvasive indices were not used. By using hepatic fibrosis and steatosis indices such as fatty liver index6 and fibrosis-4 index7 instead of or in addition to liver ultrasound, which was employed only during specific years of the NHANES dataset, the study period could be significantly extended, and a large-scale evaluation of the general population would be possible. Nevertheless, as a study targeting the general population in the United States, Gangireddy et al.’s study5 is meaningful and proves a relationship between hepatic fibrosis and steatosis and MetS. Therefore, further detailed analysis using noninvasive or invasive methods is needed to determine the direct association between hepatic fibrosis and steatosis and MetS. In addition, multi-ethnic-group studies would give us more concrete data regarding the impact of MetS on hepatic fibrosis and steatosis and improve the generalizability of these findings across various populations.
{"title":"Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61-9).","authors":"Young-Gyun Seo","doi":"10.7570/jomes22049","DOIUrl":"https://doi.org/10.7570/jomes22049","url":null,"abstract":"J Obes Metab Syndr 2022;31:350-351 Nonalcoholic fatty liver disease has a worldwide prevalence of 25%, which includes diseases ranging from steatosis to steatohepatitis, and has a bidirectional association with metabolic syndrome (MetS).1 Although a few studies have investigated the association between liver fibrosis and MetS, their findings have been controversial. A recent cohort study of a large patient-centered medical home found that a heavy burden of MetS components was associated with high or indeterminate risk for advanced fibrosis when noninvasive indices were used.2 The results of studies evaluating fibrosis confirmed by liver biopsy were different. MetS was not significantly related to advanced liver fibrosis in biopsy-proven metabolic dysfunction-associated fatty liver disease patients3 and MetS was not associated with hepatic fibrosis among individuals with hereditary hemochromatosis.4 Gangireddy et al.5 reported useful findings in an article entitled “Hepatic fibrosis and steatosis in metabolic syndrome.” In analysis using National Health and Nutrition Examination Survey (NHANES) data, 26% of the participants had steatosis; 7.5% had fibrosis; and 3.3% had fibrosis without steatosis. The adjusted odds ratios were 4.12 for steatosis, 3.34 for fibrosis, and 2.67 for fibrosis without steatosis in participants with MetS compared to those without. The strength of Gangireddy et al.’s study5 is that it was population-scale study conducted in the United States. It also has some strengths in that hepatic fibrosis and steatosis were evaluated through liver ultrasound. However, as mentioned in the paper, the fact that hepatic fibrosis and steatosis were not evaluated by liver biopsy is one limitation, and it is necessary to consider a method to address this weakness. Another limitation is that noninvasive indices were not used. By using hepatic fibrosis and steatosis indices such as fatty liver index6 and fibrosis-4 index7 instead of or in addition to liver ultrasound, which was employed only during specific years of the NHANES dataset, the study period could be significantly extended, and a large-scale evaluation of the general population would be possible. Nevertheless, as a study targeting the general population in the United States, Gangireddy et al.’s study5 is meaningful and proves a relationship between hepatic fibrosis and steatosis and MetS. Therefore, further detailed analysis using noninvasive or invasive methods is needed to determine the direct association between hepatic fibrosis and steatosis and MetS. In addition, multi-ethnic-group studies would give us more concrete data regarding the impact of MetS on hepatic fibrosis and steatosis and improve the generalizability of these findings across various populations.","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"350-351"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/1f/jomes-31-4-350.PMC9828699.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Gangwon Obesity and Metabolic Syndrome Study: Methods and Initial Baseline Data. 江原肥胖和代谢综合征研究:方法和初始基线数据。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22064
Yoon Jeong Cho, Sohyun Park, Sung Soo Kim, Hyo Jin Park, Jang Won Son, Tae Kyung Lee, Sangmo Hong, Jee-Hyun Kang, Seon Mee Kim, Yang-Hyun Kim, Won Jun Kim, Young Eun Seo, Yoosuk An, Sang Youl Rhee, Suk Chon, Sookyoung Jeon, Kyungho Park, Bong-Soo Kim, Chang Beom Lee, Kyoung-Kon Kim, Jung Eun Lee

Background: The prevalence of obesity has been continuously increasing, especially in rural areas of South Korea. Therefore, it is important to examine various genetic, behavioral, and environmental factors associated with obesity in these rural areas. The Korean Society for the Study of Obesity commenced a community-based prospective cohort study of the Gangwon area called the Gangwon Obesity and Metabolic Syndrome (GOMS) study to investigate longitudinal changes in the status of obesity and its related factors.

Methods: A total of 317 adults 40-69 years of age were recruited from Hongcheon and Inje districts, Gangwon province, as part of the first wave of this cohort study. Information on participants' demographic, behavioral, psychological, dietary, and environmental factors and past medical histories were collected by self-administered questionnaires and interviewer-administered questionnaires. Anthropometric measurements, blood tests, and a hand grip strength test were performed, and skin keratin and stool samples were collected. Among the 317 enrolled subjects, two participants who did not have anthropometric data were excluded from the data analyses, resulting in an inclusion of a total of 315 participants.

Results: The mean age of the 315 participants in the GOMS initial baseline survey was 58.5 years old, 87 of them were men, and the mean body mass index was 24.7±3.7 kg/m2. Among all participants, 48.9% had hypertension, 21.4% had diabetes mellitus (DM), 55.6% had dyslipidemia, and 46.0% had metabolic syndrome (MS). Both the prevalence rates of DM and MS were significantly higher in men.

Conclusion: The first baseline survey of the GOMS study was initiated, and a more detailed analysis of respondents' data is expected to be continued. Further follow-up and additional recruitment will allow the investigation of risk factors and the etiology of obesity and its comorbidities in rural areas of Gangwon province.

背景:韩国的肥胖患病率持续上升,尤其是在农村地区。因此,研究与这些农村地区肥胖有关的各种遗传、行为和环境因素是很重要的。韩国肥胖研究学会在江原地区开展了一项以社区为基础的前瞻性队列研究,名为江原肥胖和代谢综合征(GOMS)研究,以调查肥胖状况的纵向变化及其相关因素。方法:作为第一波队列研究的一部分,从江原道洪川和仁济地区招募了317名40-69岁的成年人。参与者的人口统计、行为、心理、饮食、环境因素和既往病史信息通过自我填写的问卷和访谈者填写的问卷收集。进行了人体测量、血液测试和手握力测试,并收集了皮肤角蛋白和粪便样本。在317名入组受试者中,2名没有人体测量数据的受试者被排除在数据分析之外,共纳入315名受试者。结果:GOMS初始基线调查315名参与者的平均年龄为58.5岁,其中男性87人,平均体重指数为24.7±3.7 kg/m2。在所有参与者中,48.9%患有高血压,21.4%患有糖尿病,55.6%患有血脂异常,46.0%患有代谢综合征。男性糖尿病和多发性硬化症的患病率均明显高于男性。结论:GOMS研究的第一次基线调查已经开始,预计将继续对受访者的数据进行更详细的分析。进一步的随访和额外的招募将允许调查江原道农村地区肥胖及其合并症的危险因素和病因。
{"title":"The Gangwon Obesity and Metabolic Syndrome Study: Methods and Initial Baseline Data.","authors":"Yoon Jeong Cho,&nbsp;Sohyun Park,&nbsp;Sung Soo Kim,&nbsp;Hyo Jin Park,&nbsp;Jang Won Son,&nbsp;Tae Kyung Lee,&nbsp;Sangmo Hong,&nbsp;Jee-Hyun Kang,&nbsp;Seon Mee Kim,&nbsp;Yang-Hyun Kim,&nbsp;Won Jun Kim,&nbsp;Young Eun Seo,&nbsp;Yoosuk An,&nbsp;Sang Youl Rhee,&nbsp;Suk Chon,&nbsp;Sookyoung Jeon,&nbsp;Kyungho Park,&nbsp;Bong-Soo Kim,&nbsp;Chang Beom Lee,&nbsp;Kyoung-Kon Kim,&nbsp;Jung Eun Lee","doi":"10.7570/jomes22064","DOIUrl":"https://doi.org/10.7570/jomes22064","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of obesity has been continuously increasing, especially in rural areas of South Korea. Therefore, it is important to examine various genetic, behavioral, and environmental factors associated with obesity in these rural areas. The Korean Society for the Study of Obesity commenced a community-based prospective cohort study of the Gangwon area called the Gangwon Obesity and Metabolic Syndrome (GOMS) study to investigate longitudinal changes in the status of obesity and its related factors.</p><p><strong>Methods: </strong>A total of 317 adults 40-69 years of age were recruited from Hongcheon and Inje districts, Gangwon province, as part of the first wave of this cohort study. Information on participants' demographic, behavioral, psychological, dietary, and environmental factors and past medical histories were collected by self-administered questionnaires and interviewer-administered questionnaires. Anthropometric measurements, blood tests, and a hand grip strength test were performed, and skin keratin and stool samples were collected. Among the 317 enrolled subjects, two participants who did not have anthropometric data were excluded from the data analyses, resulting in an inclusion of a total of 315 participants.</p><p><strong>Results: </strong>The mean age of the 315 participants in the GOMS initial baseline survey was 58.5 years old, 87 of them were men, and the mean body mass index was 24.7±3.7 kg/m<sup>2</sup>. Among all participants, 48.9% had hypertension, 21.4% had diabetes mellitus (DM), 55.6% had dyslipidemia, and 46.0% had metabolic syndrome (MS). Both the prevalence rates of DM and MS were significantly higher in men.</p><p><strong>Conclusion: </strong>The first baseline survey of the GOMS study was initiated, and a more detailed analysis of respondents' data is expected to be continued. Further follow-up and additional recruitment will allow the investigation of risk factors and the etiology of obesity and its comorbidities in rural areas of Gangwon province.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"303-312"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/77/a5/jomes-31-4-303.PMC9828700.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handgrip Strength Is Associated with Metabolic Syndrome and Insulin Resistance in Children and Adolescents: Analysis of Korea National Health and Nutrition Examination Survey 2014-2018. 握力与儿童和青少年代谢综合征和胰岛素抵抗相关:2014-2018年韩国国家健康和营养调查分析
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22053
Hae Woon Jung, Jieun Lee, Jaehyun Kim

Background: Reduced handgrip strength (HGS) is associated with adverse cardiometabolic health outcomes. We examined HGS, metabolic syndrome (MetS), and insulin resistance (IR) in children and adolescents.

Methods: The following population-based data from 2,797 participants (aged 10-18 years) of the Korea National Health and Nutrition Examination Survey 2014-2018 were analyzed: complete anthropometric measures, HGS, MetS, and IR (subgroup with fasting insulin, n=555). HGS was analyzed as the combined HGS (CHGS) and the normalized CHGS (nCHGS=CHGS divided by body weight).

Results: At a mean age of 14.4 years, 276 participants (9.9%) had abdominal obesity, 56 (2.0%) had MetS, and 118 (20.9%) had IR. Individual components of MetS and IR were inversely associated with the nCHGS. The odds ratios (ORs) for MetS and IR decreased significantly with higher nCHGS after adjustment for sex, age, physical activity, and sedentary times. The optimal cut-off values that predicted MetS were 0.80 kg/kg (males) and 0.71 kg/kg (females), with significant associations with MetS (OR: 7.4 in males; 5.7 in females) and IR (OR: 3.3 in males; 3.2 in females) observed when nCHGS values were lower than those cut-offs.

Conclusion: HGS is associated with MetS and IR and might be a useful indicator of cardiometabolic risk factors in children and adolescents.

背景:握力降低(HGS)与不良的心脏代谢健康结果相关。我们研究了儿童和青少年的HGS、代谢综合征(MetS)和胰岛素抵抗(IR)。方法:分析2014-2018年韩国国家健康与营养调查的2797名参与者(10-18岁)的以下基于人群的数据:完整的人体测量、HGS、MetS和IR(空腹胰岛素亚组,n=555)。HGS分析为综合HGS (CHGS)和归一化CHGS (nCHGS=CHGS除以体重)。结果:平均年龄14.4岁时,276名参与者(9.9%)患有腹部肥胖,56名(2.0%)患有MetS, 118名(20.9%)患有IR。met和IR的各个成分与nCHGS呈负相关。调整性别、年龄、体力活动和久坐时间后,随着nCHGS的增加,MetS和IR的比值比(ORs)显著降低。预测MetS的最佳临界值分别为0.80 kg/kg(男性)和0.71 kg/kg(女性),与MetS有显著相关性(OR:男性7.4;女性5.7)和IR (OR:男性3.3;当nCHGS值低于这些截断值时,观察到3.2(女性)。结论:HGS与MetS和IR相关,可能是儿童和青少年心脏代谢危险因素的有用指标。
{"title":"Handgrip Strength Is Associated with Metabolic Syndrome and Insulin Resistance in Children and Adolescents: Analysis of Korea National Health and Nutrition Examination Survey 2014-2018.","authors":"Hae Woon Jung,&nbsp;Jieun Lee,&nbsp;Jaehyun Kim","doi":"10.7570/jomes22053","DOIUrl":"https://doi.org/10.7570/jomes22053","url":null,"abstract":"<p><strong>Background: </strong>Reduced handgrip strength (HGS) is associated with adverse cardiometabolic health outcomes. We examined HGS, metabolic syndrome (MetS), and insulin resistance (IR) in children and adolescents.</p><p><strong>Methods: </strong>The following population-based data from 2,797 participants (aged 10-18 years) of the Korea National Health and Nutrition Examination Survey 2014-2018 were analyzed: complete anthropometric measures, HGS, MetS, and IR (subgroup with fasting insulin, n=555). HGS was analyzed as the combined HGS (CHGS) and the normalized CHGS (nCHGS=CHGS divided by body weight).</p><p><strong>Results: </strong>At a mean age of 14.4 years, 276 participants (9.9%) had abdominal obesity, 56 (2.0%) had MetS, and 118 (20.9%) had IR. Individual components of MetS and IR were inversely associated with the nCHGS. The odds ratios (ORs) for MetS and IR decreased significantly with higher nCHGS after adjustment for sex, age, physical activity, and sedentary times. The optimal cut-off values that predicted MetS were 0.80 kg/kg (males) and 0.71 kg/kg (females), with significant associations with MetS (OR: 7.4 in males; 5.7 in females) and IR (OR: 3.3 in males; 3.2 in females) observed when nCHGS values were lower than those cut-offs.</p><p><strong>Conclusion: </strong>HGS is associated with MetS and IR and might be a useful indicator of cardiometabolic risk factors in children and adolescents.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"334-344"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/4f/jomes-31-4-334.PMC9828701.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10547374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Promising First Cohort Study in Korean Patients with Obesity and Overweight: Gangwon Obesity and Metabolic Syndrome Study. 韩国肥胖和超重患者的第一队列研究:江原肥胖和代谢综合征研究。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22068
Eun-Jung Rhee
{"title":"The Promising First Cohort Study in Korean Patients with Obesity and Overweight: Gangwon Obesity and Metabolic Syndrome Study.","authors":"Eun-Jung Rhee","doi":"10.7570/jomes22068","DOIUrl":"https://doi.org/10.7570/jomes22068","url":null,"abstract":"","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"285-286"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/7b/jomes-31-4-285.PMC9828706.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10546877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diet Therapy Using a Small Rice Bowl among Japanese Men with Diabetes: A Randomized Controlled Trial. 日本男性糖尿病患者小碗饮食疗法:一项随机对照试验。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22056
Misa Shimpo, Shiori Toga-Sato, Takahiro Tosaki

Background: This study aimed to investigate the effectiveness at 1 and 3 months of using a smaller rice bowl for diet therapy among Japanese men with type 2 diabetes.

Methods: A parallel-group randomized controlled trial was conducted at a medical clinic in Japan. The participants were men with type 2 diabetes mellitus, aged 20-80 years, with glycosylated hemoglobin <8.5%, and who ate rice one or more times per day at home. The intervention group (36 men) received a small rice bowl from which to eat the usual diet therapy, and the control group (38 men) received only the usual diet therapy.

Results: The changes in weight and body mass index among the intervention group at 1 month were significantly higher than those in the control group. There were no significant differences between the two groups at 3 months.

Conclusion: The effects of using a small rice bowl were minor and short-term.

背景:本研究旨在调查日本男性2型糖尿病患者在1个月和3个月时使用较小的饭碗进行饮食治疗的有效性。方法:在日本某医学诊所进行平行组随机对照试验。研究对象为男性2型糖尿病患者,年龄20 ~ 80岁,伴有糖化血红蛋白。结果:干预组患者1个月时体重和体质指数变化明显高于对照组。3个月时两组间无显著差异。结论:使用小碗的效果轻微且短期。
{"title":"Diet Therapy Using a Small Rice Bowl among Japanese Men with Diabetes: A Randomized Controlled Trial.","authors":"Misa Shimpo,&nbsp;Shiori Toga-Sato,&nbsp;Takahiro Tosaki","doi":"10.7570/jomes22056","DOIUrl":"https://doi.org/10.7570/jomes22056","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the effectiveness at 1 and 3 months of using a smaller rice bowl for diet therapy among Japanese men with type 2 diabetes.</p><p><strong>Methods: </strong>A parallel-group randomized controlled trial was conducted at a medical clinic in Japan. The participants were men with type 2 diabetes mellitus, aged 20-80 years, with glycosylated hemoglobin <8.5%, and who ate rice one or more times per day at home. The intervention group (36 men) received a small rice bowl from which to eat the usual diet therapy, and the control group (38 men) received only the usual diet therapy.</p><p><strong>Results: </strong>The changes in weight and body mass index among the intervention group at 1 month were significantly higher than those in the control group. There were no significant differences between the two groups at 3 months.</p><p><strong>Conclusion: </strong>The effects of using a small rice bowl were minor and short-term.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"345-349"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/03/jomes-31-4-345.PMC9828703.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10539850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-perceived Weight and Mortality in Korean Adults Based on the Korea National Health and Nutrition Examination Survey Data Linked to Cause of Death Statistics. 基于与死亡原因统计相关的韩国国家健康和营养检查调查数据的韩国成年人自我感知体重和死亡率。
IF 5.2 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-12-30 DOI: 10.7570/jomes22051
Kayoung Lee

Background: This study aimed to determine the associations between self-perceived weight, weight perception, and mortality risk among Korean adults.

Methods: Data from the 2007 to 2015 Korea National Health and Nutrition Examination Survey and the 2007 to 2019 Cause of Death Statistics were linked for this cohort study. A complex samples Cox regression analysis involving 42,453 participants (17,056 male; 25,397 female) was performed after excluding those who died within 1 year of the follow-up period, those with a history of cancer, those with cardiovascular diseases, those without body mass index (BMI) data, and those without self-perceived weight data.

Results: During 7.85 years of follow-up, the overall mortality rate was 3.8% (4.5% for male and 3.1% for female). Self-perceived thin weight status was associated with a 43% to 68% higher risk of all-cause mortality and a 2.48-times higher risk of cardiovascular mortality compared to self-perceived just right weight status after controlling for sociodemographic characteristics, health-related behaviors, underlying health status, BMI, and metabolic syndrome. After adjusting for the confounding factors, those who underestimated their weight had a 27% reduced risk of all-cause mortality than those who correctly estimated their weight. The risks of all-cause mortality and cardiovascular mortality were 2.14-times higher and 2.32-times higher, respectively, in the underweight group with an accurate weight estimation than in the normal weight group with an accurate weight estimation. However, all-cause mortality was 47% lower among participants with obesity who overestimated their weight.

Conclusion: Self-perceived thinness and accurately perceived underweight status were associated with increased risks of all-cause mortality and cardiovascular mortality among Korean adults.

背景:本研究旨在确定韩国成年人自我感知体重、体重感知和死亡风险之间的关系。方法:将2007 - 2015年韩国国家健康与营养调查数据和2007 - 2019年死亡原因统计数据进行队列研究。一项涉及42,453名参与者的复杂样本Cox回归分析(17056名男性;25,397名女性)在排除随访期1年内死亡、有癌症病史、有心血管疾病、没有身体质量指数(BMI)数据和没有自我感觉体重数据的患者后进行了研究。结果:在7.85年的随访期间,总死亡率为3.8%(男性4.5%,女性3.1%)。在控制了社会人口统计学特征、健康相关行为、潜在健康状况、BMI和代谢综合征之后,与自我认为体重正常的人相比,自我认为体重过瘦的人全因死亡率风险高出43%至68%,心血管死亡率风险高出2.48倍。在调整了混杂因素后,那些低估自己体重的人比那些正确估计自己体重的人的全因死亡率降低了27%。准确估计体重的体重不足组的全因死亡率和心血管死亡率风险分别比准确估计体重的正常组高2.14倍和2.32倍。然而,高估体重的肥胖参与者的全因死亡率要低47%。结论:在韩国成年人中,自我感知的瘦和准确感知的体重不足与全因死亡率和心血管死亡率的风险增加有关。
{"title":"Self-perceived Weight and Mortality in Korean Adults Based on the Korea National Health and Nutrition Examination Survey Data Linked to Cause of Death Statistics.","authors":"Kayoung Lee","doi":"10.7570/jomes22051","DOIUrl":"https://doi.org/10.7570/jomes22051","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to determine the associations between self-perceived weight, weight perception, and mortality risk among Korean adults.</p><p><strong>Methods: </strong>Data from the 2007 to 2015 Korea National Health and Nutrition Examination Survey and the 2007 to 2019 Cause of Death Statistics were linked for this cohort study. A complex samples Cox regression analysis involving 42,453 participants (17,056 male; 25,397 female) was performed after excluding those who died within 1 year of the follow-up period, those with a history of cancer, those with cardiovascular diseases, those without body mass index (BMI) data, and those without self-perceived weight data.</p><p><strong>Results: </strong>During 7.85 years of follow-up, the overall mortality rate was 3.8% (4.5% for male and 3.1% for female). Self-perceived thin weight status was associated with a 43% to 68% higher risk of all-cause mortality and a 2.48-times higher risk of cardiovascular mortality compared to self-perceived just right weight status after controlling for sociodemographic characteristics, health-related behaviors, underlying health status, BMI, and metabolic syndrome. After adjusting for the confounding factors, those who underestimated their weight had a 27% reduced risk of all-cause mortality than those who correctly estimated their weight. The risks of all-cause mortality and cardiovascular mortality were 2.14-times higher and 2.32-times higher, respectively, in the underweight group with an accurate weight estimation than in the normal weight group with an accurate weight estimation. However, all-cause mortality was 47% lower among participants with obesity who overestimated their weight.</p><p><strong>Conclusion: </strong>Self-perceived thinness and accurately perceived underweight status were associated with increased risks of all-cause mortality and cardiovascular mortality among Korean adults.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":"31 4","pages":"313-324"},"PeriodicalIF":5.2,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/72/jomes-31-4-313.PMC9828707.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10546876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obesity & Metabolic Syndrome
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1